40 results on '"Wood, Clive R."'
Search Results
2. Data from Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
3. Supplementary Tables1-2 from Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
4. Supplementary Methods and Materials from Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
5. Neutralization of Macrophage Migration Inhibitory Factor (MIF) by Fully Human Antibodies Correlates with Their Specificity for the β-Sheet Structure of MIF
6. An Internal Ribosome Binding Site can be Used to Select for Homologous Recombinants at an Immunoglobulin Heavy-Chain Locus
7. Antibody Drug Discovery
8. Therapeutic peptides: technological advances driving peptides into development
9. Characterization of murine Flt4 ligand/VEGF-C
10. Engagement of the PD-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
11. Identification of a Human Follicular Dendritic Cell Molecule That Stimulates Germinal Center B Cell Growth
12. A Role for CD9 Molecules in T Cell Activation
13. Fully Human Monoclonal Antibody Inhibitors of the Neonatal Fc Receptor Reduce Circulating IgG in Non-Human Primates
14. BACK MATTER
15. FRONT MATTER
16. Specific inhibition of tissue kallikrein 1 with a human monoclonal antibody reveals a potential role in airway diseases
17. Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
18. Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1
19. PD‐1 inhibits T‐cell receptor induced phosphorylation of the ZAP70/CD3ζ signalosome and downstream signaling to PKCθ
20. Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production
21. PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
22. PD-L2 is a second ligand for PD-1 and inhibits T cell activation
23. The Murine IL-13 Receptor α2: Molecular Cloning, Characterization, and Comparison with Murine IL-13 Receptor α1
24. Strategies for the application of functional genomics technology to biopharmaceutical drug discovery
25. Expression of Murine Interleukin 11 and its Receptor α‐Chain in Adult and Embryonic Tissues
26. Regulation offlt-1 expression during mouse embryogenesis suggests a role in the establishment of vascular endothelium
27. Analysis of the MurineDtkGene Identifies Conservation of Genomic Structure within a New Receptor Tyrosine Kinase Subfamily
28. Expression of interleukin-11 and its encoding mRNA by glioblastoma cells
29. Isolation of a Receptor Tyrosine Kinase (DTK) from Embryonic Stem Cells: Structure, Genetic Mapping and Analysis of Expression
30. Molecular cloning of the cDNA encoding a receptor tyrosine kinase‐related molecule with a catalytic region homologous to c‐ met
31. Regulation of flt-1 expression during mouse embryogenesis suggests a role in the establishment of vascular endothelium.
32. The influence of messenger RNA secondary structure on expression of an immunoglobulin heavy chain in Escherichia coli.
33. Assembly of functional antibodies from immunoglobulin heavy and light chains synthesised in E. coli.
34. The synthesis and in vivo assembly of functional antibodies in yeast.
35. The synthesis and in vivoassembly of functional antibodies in yeast
36. Genetically engineered antibodies
37. Assembly of functional antibodies from immunoglobulin heavy and light chains synthesised inE. coli
38. The influence of messenger RNA secondary structure on expression of an immunoglobulin heavy chain inEscherichia coli
39. A Sensitive, Nondestructive Assay for Transfected Genes
40. Engineered protein inhibitors of proteases.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.